Related Experiment Video
Updated: Feb 8, 2026
Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
Published on: July 4, 2007
Genetic Modifiers in Neurodegeneration
Nimansha Jain1, Alice S Chen-Plotkin1
1Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Purpose Of Review:
To review the evidence for genetic modifier effects in the neurodegenerative diseases Huntington's Disease (HD), Frontotemporal Lobar Degeneration (FTLD), Alzheimer's Disease (AD), and Parkinson's Disease (PD).
Recent Findings:
Increasingly, we understand human disease genetics less through the lens of single-locus/single-trait effects, and more through that of polygenic contributions to disease risk. In addition, specific examples of genetic modifier effects of the chromosome 7 gene TMEM106B on various target genes including those causal for Mendelian classes of FTLD - GRN and c9orf72 - have emerged from both genetic cohort studies and mechanistic examinations of biological pathways.
Summary:
Here, we summarize the literature reporting genetic modifier effects in HD, FTLD, AD, and PD. We further contextualize reported genetic modifier effects in these diseases in terms of insight they may lend to the concept of a polygenic landscape for the major neurodegenerative diseases.
Related Concept Videos
02:16Genetics of Speciation
01:25What is Population Genetics?
00:49What is Genetic Engineering?
02:59Animal Mitochondrial Genetics
02:18Types of Genetic Transfer Between Organisms
00:57Modified Boxplots
However, the box plot does not tell the reader about outliers - values that lie far from the center of the data. We can modify the standard box and whisker plot to identify the outliers and visualize the actual spread of the data in a sample.
Initially, we calculate the adjusted...